TIMH
ABBV icon

Tilt Investment Management Holdings’s AbbVie ABBV Stock Holding History

Tilt Investment Management Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.12M Sell
7,210
-2,185
-23% -$319K 1.21% 15
2023
Q3 		$1.4M Hold
9,395
– – 1% 22
2023
Q2 		$1.27M Hold
9,395
– – 0.84% 27
2023
Q1 		$1.48M Buy
9,395
+1,197
+15% +$183K 1.09% 21
2022
Q4 		$1.32M Buy
+8,198
New +$1.26M 1.12% 22

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tilt Investment Management Holdings's ABBV Position: Q4 2023 in Review

Tilt Investment Management Holdings reduced its AbbVie (ABBV) stake by 23% in Q4 2023, selling an estimated $319K and leaving 7,210 shares worth $1.12M. The position accounts for 1.21% of the portfolio, ranked #15.

Tilt Investment Management Holdings first reported a position in ABBV in Q4 2022 and has held it in 5 quarters since. The position peaked at $1.48M in Q1 2023. 3,323 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Tilt Investment Management Holdings held 7,210 shares of AbbVie worth $1.12M as of Q4 2023.
  • Tilt Investment Management Holdings sold 2,185 AbbVie shares in Q4 2023, an estimated $319K.
  • AbbVie made up 1.21% of Tilt Investment Management Holdings's portfolio in Q4 2023, its #15 holding.
  • Tilt Investment Management Holdings first reported a position in AbbVie in Q4 2022 and has held it in 5 quarters since.
  • Tilt Investment Management Holdings's AbbVie position peaked at $1.48M in Q1 2023.
  • 3,323 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q4 2023, filed 31 Jan 2024.